[
  {
    "question": "pregnant leady with Migraine needs prophylactic what is the best?",
    "option_a": "Propranolol",
    "option_b": "topamax",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Headache",
    "explanation": "Migraine prophylaxis in pregnant patients must balance efficacy with fetal safety. Beta blockers, particularly propranolol, have long been used for migraine prevention and are among the preferred agents in pregnancy when prophylaxis is needed. Migraines involve complex neurovascular mechanisms including neuronal hyperexcitability and dysregulation of cerebral blood flow. Beta blockers such as propranolol modulate these processes by reducing sympathetic nervous system activation, which may help stabilize vascular tone. Pregnant patients with frequent or severe migraine attacks may benefit from prophylactic therapy to reduce the frequency and severity of attacks. Propranolol has been shown to be effective and is relatively safe in pregnancy when dosed appropriately, though careful monitoring is required. The diagnosis of migraine is clinical, based on a history of recurrent headaches with associated features like photophobia, phonophobia, nausea, and sometimes aura. In pregnancy, it is essential to rule out other causes of headache such as preeclampsia or secondary headaches from intracranial pathology. First-line prophylactic treatment for migraines in pregnant patients is a beta blocker such as propranolol, given its favorable safety profile. Other options, like topiramate, are contraindicated in pregnancy due to their teratogenic potential. Non-pharmacological measures, including lifestyle modifications, also play a significant role. In lactating women, propranolol is generally considered safe as only low levels are excreted in breast milk. Option A (Propranolol) is correct. Topiramate (Option B) is contraindicated in pregnancy because of its high teratogenic risk, including cleft lip/palate and other congenital malformations. Other unlisted options were less appropriate given safety or efficacy concerns during pregnancy. 1. Propranolol is one of the most commonly used prophylactic agents for migraines in pregnancy when benefits outweigh potential risks. 2. Always consider the teratogenicity of medications in pregnant patients. 3. Non-pharmacologic interventions should be part of a comprehensive migraine management plan during pregnancy. The latest guidelines from the American College of Obstetricians and Gynecologists (ACOG) and headache societies support the use of beta blockers, including propranolol, as first-line prophylaxis for migraines in pregnancy due to their safety profile, while cautioning against the use of agents like topiramate.",
    "exam_year": "2021",
    "exam_type": "Promotion"
  },
  {
    "question": "Patient presented with with papilledema and headache (IIH) what is your next step :",
    "option_a": "Acetazolamide",
    "option_b": "topomax",
    "option_c": "VP shunt",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Headache",
    "explanation": "Idiopathic Intracranial Hypertension (IIH), also known as pseudotumor cerebri, is a disorder characterized by increased intracranial pressure with normal brain imaging and cerebrospinal fluid composition. Papilledema is a hallmark clinical finding. IIH is believed to result from impaired cerebrospinal fluid absorption or increased venous pressure, leading to elevated intracranial pressure. It is most commonly seen in obese women of childbearing age. The increased pressure can result in optic nerve swelling, potentially leading to vision loss if untreated. Patients often present with headaches, transient visual obscurations, pulsatile tinnitus, and papilledema on examination. Early detection is essential to prevent permanent visual deficits. The evaluation includes neuroimaging (MRI/MRV) to exclude other causes (such as a mass or venous sinus thrombosis) and a lumbar puncture to measure the opening pressure and analyze CSF composition. Differential diagnoses include secondary intracranial hypertension, cerebral venous sinus thrombosis, and ocular pathologies. The first-line treatment for IIH is acetazolamide, a carbonic anhydrase inhibitor that reduces CSF production. Weight loss is also a critical component of management. If medical therapy fails or there is progressive vision loss, surgical options such as optic nerve sheath fenestration or CSF shunting (VP shunt) may be considered. In pregnant patients, acetazolamide is classified as Category C; its use should be carefully considered by weighing potential risks and benefits with input from a multidisciplinary team. Option A (Acetazolamide) is the correct next step in managing IIH in a patient presenting with papilledema and headache. Topiramate (Option B) has some off-label use due to its weight loss benefits but is not first-line therapy. A VP shunt (Option C) is generally reserved for refractory cases or those with significant visual compromise. 1. Early treatment with acetazolamide can reduce CSF production and lower intracranial pressure, preventing vision loss. 2. Weight loss is a cornerstone in long-term management of IIH. 3. Regular ophthalmologic evaluations are essential to monitor for progression. Recent guidelines and studies support acetazolamide as the first-line agent for IIH. Ongoing research is evaluating alternative medical therapies, but current evidence continues to validate acetazolamide's role, with surgical intervention reserved for refractory or vision-threatening cases.",
    "exam_year": "2021",
    "exam_type": "Promotion"
  },
  {
    "question": "Pt w headache photophobia and phonophobia n/v, her mother said she had some time menstrual related headache and her sis has headache that wants to stay in a calm room dx?",
    "option_a": "Menstrual migraine",
    "option_b": "migraine without aura",
    "option_c": "Tacs",
    "option_d": "",
    "option_e": "",
    "correct_answer": "B",
    "subspecialty": "Headache",
    "explanation": "Migraine is a primary headache disorder characterized by recurrent attacks of moderate-to-severe headache, often accompanied by nausea, and sensitivities to light (photophobia) and sound (phonophobia). A family history of migraine is common, supporting its genetic predisposition. The pathophysiology of migraine involves neuronal hyperexcitability and abnormal processing of sensory stimuli, along with alterations in cerebral blood flow. The disorder is multifactorial, involving both genetic and environmental factors. Menstrual migraines are considered a subtype of migraine without aura, influenced by hormonal fluctuations. The patient's symptoms\u2014headache with photophobia, phonophobia, and nausea/vomiting\u2014are classic for migraine. Although a menstrual association in the family history may hint at menstrual migraine, the overall presentation aligns with migraine without aura, which is the most common type of migraine. The diagnosis is clinical and based on established criteria (e.g., International Classification of Headache Disorders). Differential diagnoses include tension-type headache (usually milder and lacking the migrainous features such as nausea and sensory sensitivities) and cluster headache (typically associated with autonomic symptoms and occurring in clusters). Management of migraine is twofold: acute treatment during attacks (e.g., NSAIDs, triptans) and prophylactic therapy for patients with frequent attacks. In women, especially those of childbearing age, treatment choice must consider pregnancy and lactation safety. During pregnancy, for example, acetaminophen is recommended for acute treatment, while prophylaxis may include beta blockers like propranolol if necessary, with caution regarding dose and monitoring. Option B (migraine without aura) is the best answer given the symptoms of photophobia, phonophobia, and nausea/vomiting. Option A (menstrual migraine) implies a headache exclusively linked to the menstrual cycle, which is not explicitly established in this scenario. Option C (TACs) refers to Trigeminal Autonomic Cephalalgias, which have distinct autonomic features not described here. 1. Migraine without aura is the most common form of migraine and can present with significant nausea and light/sound sensitivity. 2. Familial history of migraine is common and supports the diagnosis. 3. Menstrual migraine is a subtype of migraine without aura and requires a clear temporal relationship with menstruation for diagnosis. Current guidelines emphasize the importance of classifying migraines based on aura presence and the relationship with the menstrual cycle. Recent research continues to refine prophylactic and abortive treatment strategies, with ongoing studies focusing on the safety of migraine medications in women who are pregnant or lactating.",
    "exam_year": "2021",
    "exam_type": "Promotion"
  },
  {
    "question": "Case with CADSIL (History of Migraine, mood disorders and memory):",
    "option_a": "Notch 3",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Headache",
    "explanation": "CADASIL (Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy) is a hereditary small vessel disease. Its hallmark is a mutation in the Notch3 gene, which explains the association with migraine (often with aura), mood disturbances, and progressive cognitive decline. Mutations in the Notch3 gene lead to abnormal function and degeneration of vascular smooth muscle cells, with subsequent accumulation of granular osmiophilic material within arterial walls. This results in an arteriopathy that causes subcortical ischemic events and white matter changes seen on neuroimaging. Recent studies using advanced imaging techniques have enhanced our understanding of the microvascular changes in CADASIL. Patients with CADASIL often present in mid-adulthood with recurrent migraines (frequently with aura), mood disturbances (including depression), and memory impairment. These clinical manifestations correlate with the progressive subcortical infarcts and leukoencephalopathy evident on MRI. Diagnosis is based on a combination of clinical history (noting migraine with aura, mood changes, cognitive decline), characteristic MRI findings (diffuse white matter lesions, particularly in the anterior temporal poles and external capsules), and confirmatory genetic testing for the Notch3 mutation. Differential diagnoses include sporadic subcortical ischemic disease, other hereditary leukoencephalopathies, and multiple sclerosis, which can be differentiated by distribution of lesions and genetic testing. There is no curative treatment for CADASIL. Management is largely supportive and includes controlling vascular risk factors (such as hypertension and hyperlipidemia), symptomatic management of migraines, and addressing mood and cognitive issues. Currently, no disease\u2010modifying therapies exist. In pregnancy, careful blood pressure management is important and many migraine treatments can be used with caution, while during lactation, medication choice should be guided by safety profiles and breastfeeding compatibility. Option A, Notch3, is the correct answer, as mutations in the Notch3 gene are the genetic basis of CADASIL. Other options, if provided, would not be related to the pathogenesis of CADASIL. 1. CADASIL is an important cause of early-onset stroke and migraine with aura. 2. MRI findings typically include white matter lesions in the anterior temporal regions. 3. Genetic testing for Notch3 confirms the diagnosis. Recent research has focused on early identification using advanced neuroimaging and genetic screening. Although no targeted therapy exists yet, studies are ongoing to explore potential disease-modifying treatments and the impact of risk factor management on disease progression.",
    "exam_year": "2022",
    "exam_type": "Promotion"
  },
  {
    "question": "Severe periorbital episodic headache lasting 5mins. What is the MC associated feature?",
    "option_a": "Lacrimation",
    "option_b": "Conjunctival injection",
    "option_c": "Horner sym",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Headache",
    "explanation": "This question concerns a short-lasting unilateral headache located around the eye (periorbital), which is characteristic of a subgroup of trigeminal autonomic cephalalgias (TACs), such as SUNCT (Short-lasting Unilateral Neuralgiform headache attacks with Conjunctival injection and Tearing) or paroxysmal hemicrania. The underlying mechanism involves activation of the trigeminal-autonomic reflex with hypothalamic involvement. This results in the simultaneous occurrence of severe pain and cranial autonomic symptoms via parasympathetic outflow, which manifests as lacrimation and conjunctival injection. Patients typically experience intense, brief episodes of periorbital pain accompanied by ipsilateral autonomic signs, most notably lacrimation. The episodic nature and very short duration (around 5 minutes) differentiate these headaches from longer-lasting TACs like cluster headache. The diagnostic workup includes a detailed history and examination focusing on headache characteristics and associated autonomic features. Differential diagnoses include cluster headache (usually longer duration of 15\u2013180 minutes), paroxysmal hemicrania (attacks lasting 2\u201330 minutes that respond to indomethacin), and SUNCT/SUNA syndromes. Neuroimaging may be used to rule out secondary causes. Management is based on the specific TAC diagnosed. For instance, indomethacin is effective for paroxysmal hemicrania, while the treatment of SUNCT is challenging and may include options like lamotrigine or topiramate. In acute settings, oxygen therapy and other symptomatic treatments can be considered. Pregnancy and lactation require careful medication selection; for example, oxygen remains safe, while many oral options might be used only with caution and after risk\u2013benefit discussion. Option A (Lacrimation) is marked correct because lacrimation is one of the most consistently reported and prominent autonomic features in these brief, severe headache syndromes. Option B, conjunctival injection, is also common but the question asks for the most common associated feature. Option C (Horner syndrome) is less typical in TACs like SUNCT or paroxysmal hemicrania. 1. The simultaneous presence of severe periorbital pain and autonomic signs (especially lacrimation) is a key feature of TACs. 2. The very short duration of attacks (around 5 minutes) helps distinguish these conditions from cluster headache. 3. Accurate history taking is essential for proper classification and treatment. Recent neuroimaging studies have highlighted the role of the hypothalamus in TACs. Updated ICHD-3 criteria further refine the diagnostic approach to SUNCT and related syndromes, guiding both clinical recognition and individualized management strategies.",
    "exam_year": "2023",
    "exam_type": "Promotion"
  },
  {
    "question": "Severe headache with typical migraine feature had previous episodes during menstruation. Dx?",
    "option_a": "Migraine without aura",
    "option_b": "Menstrual migraine",
    "option_c": "Abdominal migraine",
    "option_d": "",
    "option_e": "",
    "correct_answer": "B",
    "subspecialty": "Headache",
    "explanation": "The question describes a typical migraine headache that occurs in relation to menstruation. Menstrual migraine is a recognized subtype of migraine that is temporally linked to the menstrual cycle. Hormonal fluctuations, particularly the drop in estrogen levels that occurs just before or during menstruation, are known to trigger migraine attacks. This hormonal trigger leads to increased neuronal excitability and alterations in pain pathways. Women often report that their migraine attacks are more severe, longer in duration, or more difficult to treat during menstrual periods. This temporal relationship distinguishes menstrual migraine from other forms of migraine. Diagnosis is primarily clinical, based on a detailed menstrual and headache history. According to the ICHD criteria, menstrual migraine can be 'pure' (occurring exclusively during the menstrual period) or 'menstrually related' (occurring during menstruation but also at other times). Differential diagnoses include other primary headaches or secondary causes of headache; however, the clear cyclical pattern usually points to menstrual migraine. The management of menstrual migraine includes acute treatment (using NSAIDs, triptans) and, in cases where attacks are predictable and severe, short-term perimenstrual prophylaxis (e.g., using frovatriptan, zolmitriptan, or NSAIDs). For patients who are pregnant or lactating, treatment options must be carefully considered: NSAIDs are generally avoided in late pregnancy, and many triptans are category C \u2013 decisions should be individualized based on risk-benefit analysis and current guidelines. Option B, Menstrual migraine, is correct because it specifically describes migraine attacks linked to menstruation. Option A (migraine without aura) is a broader category that does not account for the menstrual association, and Option C (abdominal migraine) is typically seen in children and presents with episodic abdominal pain rather than head pain. 1. A clear temporal association with the menstrual cycle is key to diagnosing menstrual migraine. 2. Perimenstrual prophylaxis can be highly effective in reducing the frequency and severity of attacks. 3. Hormonal fluctuations (especially estrogen drop) are a major trigger in susceptible women. Recent guidelines from the International Headache Society and other bodies emphasize the importance of hormonal influences in migraine pathogenesis. Updated research supports the use of short-term prophylactic strategies around the menstrual period to improve quality of life in affected women.",
    "exam_year": "2023",
    "exam_type": "Promotion"
  },
  {
    "question": "Pregnant migraine patient, which prophylactic is suitable:",
    "option_a": "Lamictal",
    "option_b": "Topiramate",
    "option_c": "Propranolol",
    "option_d": "",
    "option_e": "",
    "correct_answer": "C",
    "subspecialty": "Headache",
    "explanation": "Migraine prophylaxis in special populations, such as pregnant patients, requires balancing efficacy with safety. Beta\u2010blockers, particularly propranolol, have been well studied and are among the first-line preventive medications for migraine. Beta-blockers are thought to reduce migraine frequency by stabilizing vascular tone and modulating central noradrenergic activity. Their prophylactic effect is achieved through inhibition of adrenergic receptors involved in the pathogenesis of migraine. Pregnant patients with frequent or disabling migraines may benefit from prophylactic therapy. Propranolol is a long-established option with a relatively well-known safety profile in pregnancy when used at appropriate doses, although it requires monitoring for potential fetal growth restriction. The decision to initiate prophylaxis involves confirming the diagnosis of migraine, assessing attack frequency and severity, and evaluating the risk\u2013benefit profile of prophylactic medications in pregnancy. Differential diagnosis should rule out secondary headaches and other benign causes before initiating long-term prophylaxis. First-line prophylaxis in pregnant migraine patients often involves beta-blockers such as propranolol, given its demonstrated efficacy. When using propranolol during pregnancy, clinicians should use the lowest effective dose and monitor fetal growth closely. Second-line options may include other agents; however, medications like topiramate are contraindicated due to teratogenicity (risk of cleft palate and neural tube defects) and lamotrigine is not conventionally used for migraine prophylaxis. During lactation, propranolol is generally considered acceptable, although monitoring for neonatal bradycardia is advised. Option C, Propranolol, is correct. It is widely used for migraine prophylaxis and has an acceptable safety profile in pregnancy when monitored appropriately. Option B, Topiramate, is contraindicated in pregnancy due to its high teratogenic risk, and Option A, Lamictal (lamotrigine), is not a standard prophylactic treatment for migraine. 1. Propranolol is one of the few migraine prophylactic agents with an established track record in pregnancy. 2. Always use the lowest effective dose in pregnant patients. 3. Avoid teratogenic medications like topiramate in women who are pregnant or planning pregnancy. Current guidelines from obstetrics and neurology societies support the use of beta-blockers such as propranolol for migraine prophylaxis in pregnancy, with careful monitoring. Ongoing research continues to refine risk\u2013benefit profiles for various prophylactic agents in pregnant and lactating patients.",
    "exam_year": "2023",
    "exam_type": "Promotion"
  },
  {
    "question": "Unilateral severe periorbital headache with autonomic features lasting 10-15 mins, up to 10x per day. What to give?",
    "option_a": "Verapamil",
    "option_b": "Indomethacin",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "B",
    "subspecialty": "Headache",
    "explanation": "This headache syndrome is one of the trigeminal autonomic cephalalgias (TACs) characterized by unilateral, severe, periorbital pain accompanied by ipsilateral autonomic features. The classic description of paroxysmal hemicrania includes short-lasting episodes (2\u201330 minutes) occurring frequently throughout the day with a dramatic response to indomethacin, which is pathognomonic for the condition. Although the precise mechanism is not completely understood, paroxysmal hemicrania involves activation of the trigeminal vascular system and autonomic pathways possibly mediated by hypothalamic dysfunction. This activation likely increases the release of inflammatory mediators and neuropeptides (e.g., calcitonin gene-related peptide, CGRP). The unique indomethacin responsiveness may be due to its inhibition of prostaglandin synthesis, thereby dampening the inflammatory cascade that contributes to the pain and autonomic symptoms. Patients typically present with unilateral periorbital or temporal pain with associated autonomic features such as lacrimation, nasal congestion, and ptosis. The attacks are short in duration (typically 10\u201315 minutes as described) but occur multiple times per day (up to 10 or more episodes). This clinical picture differentiates paroxysmal hemicrania from other TACs such as cluster headache, which generally has longer attack durations and fewer attacks per day. The diagnosis is established based on the clinical history, the pattern of headache attacks, and, importantly, the headache\u2019s dramatic response to indomethacin. The differential diagnosis includes cluster headache (attacks last 15\u2013180 minutes with fewer daily episodes and a different treatment profile), SUNCT/SUNA (short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing, which are usually even shorter in duration, often lasting seconds to minutes), and, rarely, trigeminal neuralgia with autonomic features. A therapeutic trial of indomethacin is both diagnostic and therapeutic for paroxysmal hemicrania. First-line treatment for paroxysmal hemicrania is indomethacin, which is both diagnostic and curative. Typical dosing starts at 25-50 mg three times daily, with titration based on clinical response. Second-line treatments are generally not needed if there is a complete response; however, if indomethacin is contraindicated (e.g., in pregnant women beyond the first trimester due to risk of premature closure of the ductus arteriosus, or in those with significant gastrointestinal or cardiovascular risks), alternative options such as a cautious trial of other anti-inflammatory or prophylactic agents might be considered under specialist guidance. During lactation, indomethacin does pass into breast milk, and benefits must be weighed against potential risks with careful monitoring. Option A (Verapamil) is primarily used for the prophylaxis of cluster headache and does not produce the dramatic response seen in paroxysmal hemicrania. Option B (Indomethacin) is the correct answer because the condition is indomethacin-responsive, which is a diagnostic criterion for paroxysmal hemicrania. Options C and D were not provided and therefore are not considered. 1. Paroxysmal hemicrania is characterized by multiple short attacks of severe unilateral head pain with prominent autonomic symptoms that respond completely to indomethacin. 2. The dramatic and complete response to indomethacin is both diagnostic and therapeutic. 3. Always consider contraindications for indomethacin especially in pregnant or lactating patients and those with gastrointestinal or cardiovascular risk factors. Recent studies and guideline updates continue to endorse indomethacin as the gold-standard treatment for paroxysmal hemicrania. Ongoing research is exploring the neurobiological basis of TACs, with particular attention to hypothalamic dysregulation, which may eventually lead to new therapeutic targets. Current recommendations also emphasize careful consideration of patient-specific factors such as pregnancy and lactation when selecting treatment options.",
    "exam_year": "2023",
    "exam_type": "Promotion"
  },
  {
    "question": "In neonatal mild hypoxic ischemic encephalopathy most common presentation:",
    "option_a": "Seizures",
    "option_b": "Apnea",
    "option_c": "Hypotonia",
    "option_d": "Irritability",
    "option_e": "",
    "correct_answer": "D",
    "subspecialty": "Pediatric Neurology",
    "explanation": "Neonatal hypoxic ischemic encephalopathy (HIE) is a brain injury resulting from a period of inadequate oxygen (hypoxia) and blood flow (ischemia) around the time of birth. In its mild form, the neurological exam is often relatively preserved with subtle abnormalities. Irritability is a common clinical sign reflecting a disrupted neurobehavioral state. In mild HIE, there is a transient disturbance in brain metabolism and cellular function due to a limited period of hypoxia/ischemia. Although the injury is minor, it affects neuronal excitability and neurotransmitter regulation, leading to changes such as irritability without the severe manifestations (like seizures or profound hypotonia) seen in moderate to severe forms. Clinically, infants with mild HIE might be hyperalert or irritable, often exhibiting feeding difficulties and abnormal reflexes. Unlike moderate or severe HIE, seizures, significant hypotonia, or apnea are less common, making irritability the hallmark presentation in these cases. The diagnosis primarily rests on clinical evaluation (APGAR scores, neurological exam) and supporting investigations such as brain imaging if needed. Differential diagnoses include neonatal withdrawal syndrome, metabolic disturbances, or sepsis, which can also present with irritability; however, the context of perinatal hypoxia supports HIE. For mild HIE, management is largely supportive, focusing on monitoring, ensuring adequate feeding, and maintaining normothermia. Unlike moderate/severe HIE, therapeutic hypothermia is usually not indicated. In managing neonates, special attention is paid to fluid balance, avoidance of further hypoxic events, and in cases involving pregnancy, maternal risk factors are managed appropriately. Option D (Irritability) is correct because it reflects the subtle neurobehavioral disturbances seen in mild HIE. Options A (Seizures), B (Apnea), and C (Hypotonia) are more characteristic of moderate to severe HIE, where more significant neuronal injury is present. 1. In mild HIE, the infant may appear irritable and hyperalert rather than lethargic. 2. Early recognition and supportive care are key to preventing progression of injury. 3. Neurological assessment in the first hours of life is critical for accurate grading. Recent research emphasizes the importance of clinical grading in HIE for prognostication. While therapeutic hypothermia has clear benefits in moderate to severe HIE, current guidelines recommend that infants with mild HIE be managed conservatively with vigilant supportive care and monitoring.",
    "exam_year": "2018",
    "exam_type": "Part I"
  },
  {
    "question": "According to resources allocation, to build a children hospital, in choosing the location which is the correct statement:",
    "option_a": "In area with low cost",
    "option_b": "In area with large population",
    "option_c": "In area with large number of children",
    "option_d": "Population interested in health care system",
    "option_e": "",
    "correct_answer": "C",
    "subspecialty": "Pediatric Neurology",
    "explanation": "When allocating resources for healthcare infrastructure such as a children\u2019s hospital, epidemiologic data and demographic analysis guide the decision. The key principle is ensuring that the facility meets the specific needs of the targeted population\u2014in this case, children. While not a disease process, the allocation decision is influenced by the 'burden of disease' concept. This relies on understanding the local prevalence of pediatric conditions and the distribution of the pediatric population. A children\u2019s hospital primarily serves pediatric patients. Therefore, a location with a high concentration of children is most relevant to ensure that the facility is utilized effectively and can serve the community\u2019s healthcare needs. In a planning context, a 'diagnostic' approach involves epidemiological studies, population surveys, and analysis of healthcare utilization. Differential considerations may include areas with large general populations or high interest in healthcare. However, the specificity of a high number of children directly correlates with the hospital\u2019s primary clientele. The tiered planning approach includes first identifying target demographic (children), evaluating population density, assessing competing healthcare facilities, and then considering economic factors. For areas with large pediatric populations, resources may be allocated first to ensure accessibility. In planning for pregnant mothers and young families, considerations include proximity to maternity services and pediatric care, ensuring continuity from birth through childhood. Option C (In area with large number of children) is the best choice because it directly targets the demographic that the hospital is designed to serve. Option A (Low cost) may reduce expenses but does not guarantee patient volume. Option B (Large population) is too general since a large population may have few children. Option D (Population interested in health care system) is subjective and may not align with need-based allocation. 1. Children's hospitals are most effective when located in areas with high pediatric density. 2. Demographic analysis is critical in resource allocation for healthcare infrastructure. 3. Complementary services such as maternity care are important location considerations. Recent healthcare planning guidelines underscore the importance of demographic data and utilization rates. Urban planning models now incorporate detailed age and socioeconomic analyses to ensure that pediatric services are optimally positioned to meet community needs.",
    "exam_year": "2018",
    "exam_type": "Part I"
  },
  {
    "question": "Scenario of infantile spasms, EEG is provided and ask about EEG description",
    "option_a": "Hypsarrhythmia",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Pediatric Neurology",
    "explanation": "Infantile spasms (West syndrome) is a severe form of childhood epilepsy characterized by spasms, developmental regression, and a unique electroencephalographic pattern known as hypsarrhythmia. The underlying mechanism involves disorganized neuronal firing in the developing brain. The EEG pattern hypsarrhythmia reflects chaotic, high-amplitude, and multifocal spikes with a disorganized background. This disorganization is thought to result from widespread cortical dysfunction during critical periods of brain development. Clinically, infantile spasms are manifested by brief, symmetric contractions of the neck, trunk, and extremities, often occurring in clusters. The association with developmental delay further supports the diagnosis. Hypsarrhythmia on EEG is a hallmark finding that aids in confirming the diagnosis in infants presenting with these spasms. Diagnosis is primarily based on clinical presentation and electroencephalographic findings. Differential diagnoses include benign spasms of infancy, other forms of epilepsy, and non-epileptic startle disorders. Hypsarrhythmia is distinguished by its chaotic and variable EEG pattern, which is not seen in other epileptic syndromes. First-line treatments include adrenocorticotropic hormone (ACTH) and vigabatrin, depending on the underlying etiology (with vigabatrin often preferred in tuberous sclerosis). Second-line options may include corticosteroids or other antiepileptic drugs. Although the treatment target is infants, any intervention must consider the potential long-term developmental impact. Pregnancy and lactation considerations are less directly relevant, but for lactating mothers, medication transfer into breast milk should be reviewed if the mother is treated concurrently for other conditions. Option A (Hypsarrhythmia) is correct as it is the characteristic EEG finding in infantile spasms. The other options are absent or irrelevant in this context; thus, A is the clear and correct choice. 1. Hypsarrhythmia on EEG is virtually pathognomonic for infantile spasms in the appropriate clinical context. 2. Early diagnosis and treatment are critical to prevent further neurodevelopmental deterioration. 3. An interdisciplinary approach improves outcomes in this challenging epileptic encephalopathy. Recent guidelines stress early intervention with hormonal therapy to improve neurological outcomes in infantile spasms. Research is ongoing into the underlying molecular genetics of the syndrome and tailored therapies based on specific etiologies.",
    "exam_year": "2018",
    "exam_type": "Part I"
  },
  {
    "question": "A case about a male with external ophthalmoplegia, ptosis, onset before he was 10 \u2026 what's the diagnosis: (same exact the above question) where is the mutation:",
    "option_a": "Large delete of mitrochondia DNA",
    "option_b": "Sporadic mutation in mitrochondia DNA",
    "option_c": "Mutation in ribosomal related mitrochondia DNA",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Pediatric Neurology",
    "explanation": "Chronic Progressive External Ophthalmoplegia (CPEO) is a mitochondrial disorder characterized by progressive weakness of the extraocular muscles, leading to ptosis and ophthalmoplegia. It most commonly results from large-scale deletions in mitochondrial DNA. Mitochondrial DNA deletions impair the energy production vital for high-energy demanding tissues such as extraocular muscles. The loss of function in these muscles manifests as progressive ptosis and ophthalmoplegia. In many cases, the mutation is sporadic and results from a large deletion rather than point mutations or ribosomal DNA abnormalities. Patients may present in childhood with drooping eyelids and limited eye movements. The early onset (before age 10) is a key clinical clue, and the pattern of external ophthalmoplegia with ptosis is central to the diagnosis of CPEO, which may also be seen in syndromic conditions like Kearns-Sayre syndrome. The diagnosis of CPEO involves a detailed clinical evaluation and confirmation with genetic testing to identify mitochondrial DNA deletions. Differential diagnoses include ocular myasthenia gravis, congenital myopathies, and other mitochondrial disorders. Muscle biopsy with histochemical studies can also provide supportive evidence. Management is supportive and focuses on symptomatic treatment such as ptosis correction (surgical options) and monitoring for potential systemic involvement. There is currently no cure for CPEO. In terms of genetic counseling, mothers should be informed about the maternal inheritance pattern of mitochondrial disorders. Pregnancy and lactation considerations involve careful evaluation of the risk of mitochondrial disease transmission to offspring, though interventions remain limited. Option A (Large deletion of mitochondrial DNA) is correct because it is the characteristic genetic abnormality found in CPEO. Option B (Sporadic mutation in mitochondrial DNA) is less precise since many cases are sporadic but are typified by large-scale deletions. Option C (Mutation in ribosomal related mitochondrial DNA) is incorrect because ribosomal DNA mutations are not typical for CPEO. 1. CPEO typically presents in childhood with progressive ptosis and external ophthalmoplegia. 2. A large mitochondrial DNA deletion is the hallmark of the genetic defect in most cases. 3. Always consider mitochondrial disorders in the differential diagnosis of early-onset ophthalmoplegia. Recent mitochondrial research reinforces the relationship between single, large-scale mitochondrial DNA deletions and CPEO. Advances in genetic testing have improved diagnostic accuracy and counseling, though therapeutic options remain largely supportive.",
    "exam_year": "2018",
    "exam_type": "Part I"
  },
  {
    "question": "hypsarrhythmia Electrodecrementla repsonse in eeg is 2hz w hypsarrhythmia",
    "option_a": "states 2/sec which perfectly matches the well",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "a",
    "subspecialty": "Pediatric Neurology",
    "explanation": "Hypsarrhythmia is a chaotic, high\u2010amplitude, multifocal EEG pattern classically associated with infantile spasms. The electrodecremental response is seen during the spasm, appearing as a transient, rhythmic suppression of the background EEG activity, typically at a rate of about 2 Hz. Infantile spasms, often part of West syndrome, are thought to result from diffuse cortical dysfunction. During a spasm, abnormal neuronal synchronization leads to a sudden drop in EEG amplitude (electrodecremental response) at roughly 2 cycles per second, reflecting transient failure of cortical inhibition. Current studies cite disruptions in neuronal migration and synaptic organization as underlying factors. Infantile spasms usually present around 4\u20138 months of age with clusters of sudden flexor or extensor spasms accompanied by developmental regression. The classic EEG finding of hypsarrhythmia with an electrodecremental response correlating with the spasms is a key diagnostic feature that guides rapid intervention. The diagnosis is largely based on clinical history and EEG findings. Differential diagnoses include other epileptic encephalopathies such as Lennox-Gastaut syndrome; however, the combination of infantile spasms, hypsarrhythmia, and the characteristic electrodecremental response at ~2 Hz helps differentiate West syndrome from other epilepsy syndromes. First-line treatment involves hormonal therapy (e.g., adrenocorticotropic hormone [ACTH] or oral corticosteroids) or vigabatrin especially in cases associated with tuberous sclerosis. Early intervention is critical to mitigate long-term neurodevelopmental deficits. Although these patients are infants (and thus not in the context of pregnancy or lactation), when managing similar epileptic disorders in older patients, current guidelines emphasize the safety profiles of medications during pregnancy and breastfeeding, with careful risk-benefit analysis and counseling. Option a states 2/sec which perfectly matches the well-documented electrodecremental response rate in hypsarrhythmia. Options b (4/sec), c (6/sec), and d (8/sec) are incorrect as these frequencies do not fit the typical electrophysiological manifestation of infantile spasms. \u2022 The electrodecremental response in infantile spasms is characteristically around 2 Hz. \u2022 Early diagnosis and treatment of West syndrome can improve developmental outcomes. \u2022 Hypsarrhythmia on EEG is chaotic and multifocal, distinguishing it from other more rhythmic epilepsy patterns. Recent guidelines by the International League Against Epilepsy (ILAE) and several pediatric neurology societies stress early EEG evaluation and treatment initiation in infants presenting with spasms. Novel research is focused on the genetic underpinnings and optimizing treatment protocols to minimize long-term cognitive sequelae.",
    "exam_year": "2019",
    "exam_type": "Part I",
    "image_url": "page_27.png"
  },
  {
    "question": "When to do brain imaging in Pediatric headache",
    "option_a": "(Unilateral symptoms) is incorrect because unilateral headache without other red flags is common in migraine. Option b (Occipital headache) is correct as it is a well",
    "option_b": "",
    "option_c": "(Photophobia) and option d (Aura) are typical features of migraine and do not independently mandate imaging.",
    "option_d": "",
    "option_e": "",
    "correct_answer": "b",
    "subspecialty": "Pediatric Neurology",
    "explanation": "In pediatric headache evaluation, certain headache localizations and accompanying features are considered red flags that may signal secondary pathology. An occipital headache is one such red flag, as it is more frequently associated with posterior fossa lesions. Posterior fossa lesions, such as tumors or Chiari malformations, may compress neural structures in the occipital region, leading to localized headache. Disruption of normal cerebrospinal fluid (CSF) dynamics or mass effect contributes to the characteristic occipital pain. Children with occipital headaches may also present with other neurological signs (eg, ataxia, vomiting, vision changes) and often have a different clinical profile compared to those with primary headache disorders like migraine, which can be unilateral but more frequently accompanied by photophobia, phonophobia, or typical aura. A thorough history and physical examination are essential. Brain imaging, preferably MRI, is warranted in children presenting with occipital headache especially if accompanied by additional red flags such as neurological deficits. Differential diagnoses include primary headaches (migraine, tension-type headache) versus secondary causes (posterior fossa brain tumors, Chiari I malformation). Current guidelines recommend neuroimaging (ideally MRI without contrast) when red flag features such as occipital headache are present in pediatric patients. The decision to image is based on the overall clinical picture rather than headache laterality alone. Although pregnancy and lactation considerations do not apply directly to pediatric patients, similar principles apply in pregnant individuals where MRI (without gadolinium) is considered safe when imaging is essential. Option a (Unilateral symptoms) is incorrect because unilateral headache without other red flags is common in migraine. Option b (Occipital headache) is correct as it is a well-recognized red flag for possible posterior fossa pathology. Option c (Photophobia) and option d (Aura) are typical features of migraine and do not independently mandate imaging. \u2022 Occipital headache in children is a red flag prompting neuroimaging. \u2022 A detailed neurological exam is crucial to identify associated signs that may indicate secondary causes. \u2022 Primary headache disorders (such as migraine) alone rarely necessitate imaging. Recent updates from the American Academy of Neurology (AAN) and headache societies advocate for a selective approach to neuroimaging in pediatric headache, emphasizing the importance of red flag symptoms such as occipital pain in guiding the decision to perform MRI.",
    "exam_year": "2019",
    "exam_type": "Part I"
  },
  {
    "question": "short stature, microcephaly, SNHL, development delay, optic atrophy",
    "option_a": "(Occipital gyral malformation) is correct as it best explains the integrated findings including optic atrophy and developmental delay. Options b (Midbrain), c (Cerebellum), and d (High basal ganglia) would not account for the visual and hearing deficits or the growth failure seen in this syndrome.",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "a",
    "subspecialty": "Pediatric Neurology",
    "explanation": "The combination of short stature, microcephaly, sensorineural hearing loss (SNHL), developmental delay, and optic atrophy suggests a congenital syndrome involving abnormal cortical development. An occipital gyral malformation specifically implicates abnormal development of the occipital lobes, which can affect both visual pathways and neurodevelopment. Gyral malformations occur due to disruptions in neuronal migration and cortical organization during brain development. When the malformation predominantly affects the occipital region, it can lead to visual pathway compromise (optic atrophy) as well as widespread developmental impairments including growth failure and hearing loss. Patients present with a constellation of neurological deficits including microcephaly and global developmental delay. The involvement of the occipital cortex is suggested by optic atrophy, and sensorineural hearing loss further supports a syndromic process affecting multiple sensory modalities. Magnetic resonance imaging (MRI) of the brain is the investigation of choice to delineate the pattern of gyral malformation. Differential diagnoses include other forms of cortical dysplasia like lissencephaly or polymicrogyria, but the specific involvement of the occipital lobes, combined with the systemic features, characterizes the syndrome more accurately. Management is multidisciplinary, involving neurology, developmental pediatrics, genetics, and rehabilitative services. Treatment is supportive, focusing on early intervention programs, special education, and addressing sensory impairments. For future pregnancies, genetic counseling is recommended. Although pregnancy/lactation issues do not directly apply to the affected child, counseling may be crucial for family planning and recurrence risk. Option a (Occipital gyral malformation) is correct as it best explains the integrated findings including optic atrophy and developmental delay. Options b (Midbrain), c (Cerebellum), and d (High basal ganglia) would not account for the visual and hearing deficits or the growth failure seen in this syndrome. \u2022 A combination of optic atrophy and SNHL with developmental delay should raise suspicion for a syndromic cortical malformation. \u2022 Occipital lobe involvement is key in explaining visual deficits. \u2022 Neuroimaging (MRI) is essential for accurate anatomical characterization. Recent neurogenetic research has improved the understanding of cortical malformations. Updated consensus guidelines recommend comprehensive neuroimaging and genetic testing in children with multisystem developmental delays to aid in diagnosis and management planning.",
    "exam_year": "2019",
    "exam_type": "Part I"
  },
  {
    "question": "Case scenario Syringomyelia (Cape like weakness distribution)\nSyringomyelia fluid-filled cyst in the spinal cord parenchyma or cystic expansion of the central canal with disruption of ependyma,\nHydromyelia cystic expansion of the central canal with ependymal lining preserved",
    "option_a": "describes syringomyelia as a fluid",
    "option_b": "(the marked answer) erroneously describes hydromyelia by implying an intact ependymal lining, which is not consistent with the case scenario of syringomyelia. Without needing details on options C and D, it is clear that the proper description for syringomyelia is given by Option A.",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Pediatric Neurology",
    "explanation": "Syringomyelia is defined as a condition in which a fluid-filled cavity, known as a syrinx, forms within the spinal cord. The hallmark difference between syringomyelia and hydromyelia is based on the integrity of the ependymal lining: in syringomyelia, the cavity disrupts or is not lined by ependymal cells, whereas hydromyelia involves an expansion of the central canal with the ependymal lining preserved. The formation of a syrinx often results from disturbances in cerebrospinal fluid (CSF) flow dynamics, which may be secondary to conditions such as Chiari I malformation, spinal trauma, or tumor. The accumulation of fluid within the spinal cord disrupts normal tissue architecture and may progressively damage adjacent neural pathways, particularly those mediating pain and temperature sensation. Clinically, syringomyelia is classically associated with a 'cape-like' distribution of loss of pain and temperature sensation over the upper extremities and back, due to the selective involvement of the decussating fibers of the spinothalamic tract in the anterior commissure. Motor deficits and weakness may also be present as the syrinx expands. Magnetic resonance imaging (MRI) of the spine is the gold standard for diagnosing syringomyelia. The key imaging findings include a fluid-filled cavity within the spinal cord that does not have an intact ependymal lining. Differential diagnoses include hydromyelia (which shows dilation of the central canal with preserved ependymal lining), intramedullary cysts, and spinal cord tumors. Detailed imaging helps differentiate these conditions based on the continuity with the central canal and the integrity of surrounding structures. Management of syringomyelia centers on addressing the underlying cause. In patients with an associated Chiari I malformation, posterior fossa decompression is typically the first-line treatment. For patients without an operative lesion or with minimal symptoms, conservative management and close observation may be appropriate. In situations where surgery is considered during pregnancy, the risks and benefits must be weighed carefully with input from neurosurgery, obstetrics, and anesthesiology, as MRI (without contrast) is generally safe during pregnancy. Postoperative medication use should also account for lactation safety profiles. Option A describes syringomyelia as a fluid-filled cyst in the spinal cord parenchyma or a cystic expansion of the central canal with disruption of the ependymal lining. This is the correct definition for syringomyelia. Option B (the marked answer) erroneously describes hydromyelia by implying an intact ependymal lining, which is not consistent with the case scenario of syringomyelia. Without needing details on options C and D, it is clear that the proper description for syringomyelia is given by Option A. \u2022 Syringomyelia classically presents with a 'cape-like' distribution of sensory loss affecting pain and temperature. \u2022 The key diagnostic difference from hydromyelia is the disruption (lack) of an intact ependymal lining in the syrinx. \u2022 MRI is the investigation of choice for analyzing the extent and nature of the spinal cord cavity. Recent studies have improved our understanding of CSF flow dynamics and the pathogenesis of syrinx formation, leading to advancements in surgical techniques. Updated guidelines emphasize early surgical intervention in patients with progressive neurological deficits, and ongoing research is focused on refining the indications for conservative versus surgical management.",
    "exam_year": "2019",
    "exam_type": "Part I"
  },
  {
    "question": "A 5-year child came with cognitive decline during 7 months old he has frequent spasm where and hypsarrhythmia he received ACTH with some improvement what is the diagnosis",
    "option_a": "West Syndrome",
    "option_b": "LGS",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Pediatric Neurology",
    "explanation": "West syndrome is an epileptic encephalopathy of infancy characterized by a triad: infantile spasms, a chaotic EEG pattern known as hypsarrhythmia, and neurodevelopmental regression. It usually presents during the first year of life. The underlying mechanism involves abnormal brain development or injury that leads to disorganized electrical activity in the brain. Hypsarrhythmia on EEG reflects this chaotic neuronal firing. Multiple etiologies, including structural brain abnormalities, metabolic disorders, and genetic conditions, can cause West syndrome. Clinically, affected infants present with clusters of spasms that may appear as sudden extensor or flexor movements, often in clusters, along with developmental delays. Early diagnosis is crucial because prompt treatment (often with ACTH) may improve outcomes, though many children may still experience developmental challenges. Diagnosis is primarily based on clinical presentation and electroencephalographic findings. Differentiating West syndrome from other epileptic encephalopathies (such as Ohtahara syndrome in neonates or Lennox-Gastaut syndrome later in childhood) involves age of onset, specific seizure types, and EEG patterns. Brain imaging may be used to identify underlying structural lesions. The first\u2010line treatment is hormonal therapy, typically with ACTH or oral corticosteroids. Vigabatrin is also used, especially in cases associated with tuberous sclerosis. Additional supportive therapies include antiepileptic medications and developmental support. In pregnancy and lactation, considerations involve using alternative treatments and careful monitoring when maternal use of medications might affect the newborn; however, West syndrome primarily affects infants, and the guidelines for neonatal management do not usually require modifications for maternal conditions. Option A, West syndrome, is correct because the presentation of infantile spasms, developmental regression, and hypsarrhythmia on EEG are pathognomonic for this condition. Option B, Lennox-Gastaut syndrome, is incorrect because it generally has a different age of onset, clinical features, and EEG findings. 1. Early recognition and treatment of infantile spasms can improve long\u2010term neurodevelopmental outcomes. 2. ACTH remains the mainstay of therapy in West syndrome. 3. Hypsarrhythmia is a classic EEG finding that helps confirm the diagnosis. Recent guidelines emphasize the importance of early initiation of therapy. Studies have shown that prompt control of spasms with ACTH or vigabatrin can reduce long-term cognitive impairment. Ongoing research is exploring genetic markers and novel treatments to further improve outcomes.",
    "exam_year": "2019",
    "exam_type": "Part I"
  },
  {
    "question": "Case of hypsarrhythmia, mental regression and infantile spasm (2 questions)",
    "option_a": "West syndrome",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Pediatric Neurology",
    "explanation": "West syndrome is defined by its triad of infantile spasms, developmental regression, and the distinctive hypsarrhythmia pattern on EEG. This syndrome is a form of epileptic encephalopathy commonly seen in infants. The disease involves disordered brain electrical activity likely due to a range of underlying etiologies, including genetic aberrations and perinatal brain injury. Hypsarrhythmia represents a chaotic neuronal firing pattern that is the hallmark of this condition. Infants typically show clusters of spasms\u2014brief, symmetrical contractions that can involve the neck, trunk, and limbs\u2014along with cognitive decline or developmental delay. Prompt treatment is critical to minimize further developmental impairment. Diagnosis relies on clinical observation of the spasms and EEG confirmation of hypsarrhythmia. Differential diagnoses include other early infantile epileptic encephalopathies (like Ohtahara syndrome in neonates) and later childhood syndromes like Lennox-Gastaut syndrome, which have distinct features. Initial treatment typically involves hormonal therapy with ACTH or corticosteroids. Vigabatrin is considered when tuberous sclerosis is implicated. Early intervention is essential to improve neurodevelopmental outcomes. Considerations for pregnancy/lactation are generally not applicable since West syndrome affects infants, but if a breastfeeding mother is on medication, potential drug transfer and effects must be monitored. Option A, West syndrome, is correct as the described triad (hypsarrhythmia, infantile spasms, and mental regression) is diagnostic for this syndrome. The absence of other options does not detract from the accuracy of this answer. 1. Hypsarrhythmia on EEG is a critical diagnostic finding in West syndrome. 2. Early treatment with ACTH can modify the long-term developmental outcome. 3. Differential diagnoses based on age and seizure type are important to consider. Recent studies underscore the importance of early diagnosis and treatment initiation in West syndrome to improve neurodevelopment. Updates in clinical guidelines continue to reinforce ACTH as a first-line therapy, and ongoing research into additional therapies is promising.",
    "exam_year": "2020",
    "exam_type": "Part I"
  },
  {
    "question": "Case of Sturge weber (hint: port wine on face) asked about what it comes with?",
    "option_a": "Renal Angiofibroma",
    "option_b": "Cardiac Rhabdomyosarcoma",
    "option_c": "Glaucoma",
    "option_d": "",
    "option_e": "",
    "correct_answer": "C",
    "subspecialty": "Pediatric Neurology",
    "explanation": "Sturge-Weber syndrome is a neurocutaneous disorder characterized by facial port-wine stains, leptomeningeal angiomas, and ocular manifestations. The facial angioma is typically located in the distribution of the trigeminal nerve. The condition results from a sporadic somatic mutation leading to vascular malformations of the skin, brain, and eyes. The abnormal blood vessel development can result in neurological complications as well as ocular issues such as glaucoma, due to increased episcleral venous pressure. Patients usually present with a port-wine stain over the face, often in the ophthalmic (V1) distribution of the trigeminal nerve. Seizures, developmental delays, and glaucoma are common. Ocular involvement is particularly significant because glaucoma can lead to irreversible vision loss if untreated. Diagnosis is based on the clinical features along with neuroimaging (MRI, CT) demonstrating leptomeningeal angiomas and calcifications. Ophthalmologic evaluation is essential to assess for glaucoma. Differential diagnoses include other phakomatoses such as tuberous sclerosis, but the presence of a port-wine stain is key for Sturge-Weber syndrome. Management involves multidisciplinary care including neurology, dermatology, and ophthalmology. For glaucoma, treatment may include topical medications (beta blockers, prostaglandin analogs) as first-line therapy, with surgical interventions reserved for refractory cases. In children, considering the impact on developing eyes, early detection and treatment are critical. While pregnancy and lactation considerations are not directly applicable, management in women with Sturge-Weber requires careful evaluation of medications if they are of childbearing potential. Option C, Glaucoma, is the correct association with Sturge-Weber syndrome. Option A (Renal Angiofibroma) and Option B (Cardiac Rhabdomyosarcoma) are not typically associated with this syndrome and are therefore incorrect. 1. A port-wine stain especially in the distribution of the trigeminal nerve should raise suspicion for Sturge-Weber syndrome. 2. Glaucoma is a common ocular complication in Sturge-Weber and should be regularly monitored. 3. Multidisciplinary management improves outcomes due to the varied involvement across systems. Recent updates emphasize the need for regular ophthalmologic evaluations in patients with Sturge-Weber syndrome to detect glaucoma early. Advances in imaging and interventional techniques continue to improve management and prognosis.",
    "exam_year": "2021",
    "exam_type": "Part I"
  },
  {
    "question": "Pediatric patients with presentations suggestive of Menkes disease (friable hair) What will you find",
    "option_a": "Low copper level",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Pediatric Neurology",
    "explanation": "Menkes disease is a rare X-linked recessive disorder of copper metabolism. It is characterized by defective copper transport resulting in systemic copper deficiency. The syndrome is classically associated with abnormal, kinky, or 'frizzy' hair, along with neurologic deterioration. The disease is due to mutations in the ATP7A gene, which encodes a copper-transporting ATPase. The defective protein impairs copper absorption and distribution, leading to low levels of copper and ceruloplasmin. This deficiency affects numerous copper-dependent enzymes, causing widespread metabolic dysfunction. Clinically, infants present with characteristic sparse, brittle, and kinky hair (often described as 'kinky hair syndrome'), along with developmental delays, hypotonia, and seizures. The deficiency in copper-dependent enzymes also leads to connective tissue abnormalities and vascular changes. Diagnosis is based on the clinical presentation (notably the hair abnormalities) and biochemical markers such as low serum copper and ceruloplasmin levels. Genetic testing confirms mutations in the ATP7A gene. Differential diagnoses include other metabolic or neurodegenerative conditions; however, the unique hair phenotype is a key distinguishing feature. Management involves early copper replacement therapy, typically in the form of subcutaneous or intravenous copper histidine. Treatment is generally most effective when started early in the disease course. Genetic counseling is crucial given its X-linked inheritance. In terms of pregnancy and lactation, mothers who are carriers should receive genetic counseling; however, direct treatment considerations mostly apply to the affected infant rather than maternal adjustments during pregnancy or lactation. Option A, Low copper level, is correct as it directly correlates with the biochemical abnormality seen in Menkes disease. The low level of copper is the hallmark finding, confirming the diagnosis. 1. The finding of sparse, kinky, and brittle hair in an infant should prompt evaluation for Menkes disease. 2. Early copper supplementation may improve outcomes, though the prognosis remains guarded. 3. Menkes disease is an X-linked disorder, making genetic counseling essential for affected families. Current research emphasizes early biochemical and genetic testing for prompt diagnosis of Menkes disease, with studies showing that early intervention with copper histidine can delay neurodegeneration. Ongoing efforts focus on novel therapeutic strategies and gene therapy, though standard treatment remains copper supplementation.",
    "exam_year": "2021",
    "exam_type": "Part I"
  }
]